Effects of biophilic virtual reality on cognitive function of patients undergoing laparoscopic surgery: study protocol for a sham randomised controlled trial.
Effects of biophilic virtual reality on cognitive function of patients undergoing laparoscopic surgery: study protocol for a sham randomised controlled trial.
复制标题
DOI:
10.1136/bmjopen-2021-052769
复制
发表时间:
2022-07-08
期刊:
影响因子:
2.9
通讯作者:
Wang, Jianhua
中科院分区:
文献类型:
--
作者:
Zhu, Binbin;Zhou, Yanling;Weng, Qiuyan;Luo, Wenjun;He, Xiuchao;Jin, Lufei;Wang, Qinwen;Gao, Bin;Harb, Ahmad Khaled Ahmad;Wang, Jianhua
Virtual reality (VR) is already being used for cognitive or emotional rehabilitation. However, its role in postoperative cognitive dysfunction (POCD) has not been fully recognised. Due to the lack of an effective postoperative follow-up system, the incidence of POCD in China is not clear, and although many drugs have been proposed to improve POCD in the animal study, their clinical applications are limited, while VR provides an innovative method to provide non-pharmacological management. This is a single-centre, randomised, double-blind, sham-controlled clinical trial. In this study, 600 patients over 55 years old undergoing laparoscopic surgery will be recruited. Participants will be randomly assigned to receive biophilic VR or sham VR (1:1 ratio), all patients have 20 min of exposure per day during the hospital stay. The primary outcome is the impact of VR on the incidence of POCD. Secondary outcomes include perioperative anxiety and instrumental activities of daily living. Changes in the performance of the neurocognitive batteries are measured by a local resident doctor. Serum samples will be collected on the day before surgery and 7 days after surgery. This trial has ethical approval from the Medical Ethics Committee of the Affiliated Hospital of Medical School of Ningbo University (KY20210302). The study is sponsored by Ningbo University and Ningbo Science and Technology Bureau. Contact: Dr. Mao Haijiao, Chair of the hospital medical Ethics committee (ndfylunli@126.com). Trial results will be submitted for publication in peer-reviewed journals, patient recruitment began in April 2021. Written informed consent is obtained for all participants. All information acquired will be disseminated via national or international conferences and published in peer-reviewed journals. ChiCTR2000040919.
登录
查看更多内容
影响因子:
1.6
作者:
Hu, Jian;Li, Chun-Jing;Wang, Dong-Xin
通讯作者:
Wang, Dong-Xin
影响因子:
3.5
作者:
Wahlin, Anders;Fordell, Helena;Malm, Jan
通讯作者:
Malm, Jan
DOI:
10.1126/science.aaw2622
发表时间:
2020-07-10
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Horowitz AM;Fan X;Bieri G;Smith LK;Sanchez-Diaz CI;Schroer AB;Gontier G;Casaletto KB;Kramer JH;Williams KE;Villeda SA
通讯作者:
Villeda SA
影响因子:
2.1
作者:
Rudolph JL;Schreiber KA;Culley DJ;McGlinchey RE;Crosby G;Levitsky S;Marcantonio ER
通讯作者:
Marcantonio ER
影响因子:
3
作者:
Prinsloo, Gabriell E.;Derman, Wayne E.;Rauch, H. G. Laurie
通讯作者:
Rauch, H. G. Laurie